Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With Food

NCT01483170 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped poor tolerability at highest dose

Conditions

Trypanosomiasis, African

Interventions

DRUG: Tablets Fexinidazole
DRUG: Placebo

Sponsor

Drugs for Neglected Diseases